Efficacy of Mirtazapine in Major Depressive Disorder With Insomnia

PHASE4CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

March 1, 2024

Conditions

Major Depressive Disorder With Insomnia

Interventions

DRUG

Mirtazapine Tablets

Mirtazapine tablet form, orally, once or twice daily, 15-45 mg

Trial Locations (1)

National Institute of Mental Health, Dhaka

All Listed Sponsors

collaborator

Sun Pharmaceutical Industries Limited

INDUSTRY

lead

National Institute of Mental Health, Dhaka

OTHER

NCT05978219 - Efficacy of Mirtazapine in Major Depressive Disorder With Insomnia | Biotech Hunter | Biotech Hunter